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Research Letter

In-hospital outcomes after bariatric surgery in
patients with heart failure
Vanessa Blumer, MD, a Stephen J. Greene, MD, a,b Miguel Ortiz, MD, d Veraprapas Kittipibul, MD, c
Gabriel A. Hernandez, MD, e Marat Fudim, MD, a,b Alejandro Lemor, MD, f Robert J. Mentz, MD, a,b and
Amanda R. Vest, MBBS, MPH g Durham, NC; Iowa City, IA; Miami, FL; Jackson, MS; Detroit, MI; and Boston, MA

Based on the largest publicly available all-payer inpatient database in the United States, this study sought to evaluate realworld outcomes after bariatric surgery among patients with heart failure. (Am Heart J 2020;230:59-62.)

An estimated 6.2 million adults in the United States (US)
have heart failure (HF), with an expected increase to more
than 8 million by 2030. 1 The obesity epidemic has been a
major contributor to this rising prevalence, and obesity
remains one of the strongest risk factors for development of
HF. 2 In contemporary trials recruiting inpatients with HF, a
fifth of patients meet body mass index (BMI) criteria for
severe obesity (BMI ≥ 40 kg/m 2). 3 Bariatric surgery,
including Roux-en-Y gastric bypass, sleeve gastrectomy,
and adjustable gastric banding, are cornerstone therapies
for the management of severe obesity. Surgical weight loss
in the broad population with obesity yields durable weight
reduction, remission of cardiovascular risk factors, and
reduced longer-term cardiovascular event rates and mortality. 4 Contemporary safety data suggest a 30-day postoperative mortality rate after bariatric surgery of <1%. 5
However, for patients with established HF, the balance of
risks and benefits from a surgical weight loss strategy is
unknown. Given this evidence gap, this study sought to
evaluate real-world outcomes after bariatric surgery among
patients with systolic and diastolic HF based upon the
largest publicly available all-payer inpatient database in the
US.
The study cohort was derived from the 2010-2015
Nationwide Inpatient Sample (NIS) database. The NIS is
compiled by the Healthcare Cost and Utilization Project
and sponsored by the Agency for Healthcare Research
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and Quality; it includes a cross-sectional, stratified sample
of approximately 20% of all discharges in the US. International Classification of Diseases, Ninth Revision,
Clinical Modification (ICD-9-CM), procedure codes
were used to identify hospitalizations of adult patients
≤18 years who underwent bariatric surgery (44.39,
44.38, and 44.31 for gastric bypass; 43.89 and 43.82 for
sleeve gastrectomy; and 44.68 and 44.95 for gastric
banding) from January 1, 2010, to September 30, 2015.
Starting October 1, 2015, the NIS transitioned to ICD-10CM; hence, our selected time frame represents the last
5 years of NIS using ICD-9-CM coding. Patients with
certain gastrointestinal malignancies were excluded (150.
XX, 151.XX, 152.XX, 157.XX, 199.XX). This approach
and the ICD-9 codes used for bariatric surgery were
based on those suggested by the American Society for
Metabolic and Bariatric Surgery and methodologies used
in previous large-scale publications analyzing postbariatric surgery outcomes. 6 , 7 We subsequently identified
patients with diagnosis of systolic HF (428.2X) or
diastolic HF (428.3X). Patients with systolic and diastolic
HF (428.4X) were included in the systolic HF group.
The primary outcome was in-hospital mortality. Secondary outcomes included mean length of hospital stay
and postoperative complications. χ 2 and t tests were
used to compare baseline characteristics, and multivariable logistic regression models were used to compare inhospital complications and mortality between groups
(non-HF vs systolic HF and non-HF vs diastolic HF).
Covariates for multivariable models included all baseline
characteristics that showed statistically significant differences between cohorts. A subgroup analysis for the
primary outcome was performed in patients identified as
undergoing surgery via laparoscopic approach (ICD-9:
44.38, 43.82, 44.68, 44.95). Two-tailed P < .05 was
considered statistically significant. Statistical analyses
were performed using Stata 14.2 (StataCorp, College
Station, TX).
The cohort included an estimated total of 793,411
patients undergoing bariatric surgery. Of these, 788,195
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Table I. Baseline characteristics of study population undergoing bariatric surgery

No. of patients (weighted)
Bariatric procedure
Roux-en-Y gastric bypass
Sleeve gastrectomy
Adjustable gastric banding
Laparoscopic approach
Patient characteristics
Age (mean ± SE)
Sex
Male
Female
Race
White
Black
Hispanic
Other
Body mass index (kg/m 2)
<35
35-39.9
40-44.9
45-49.9
50-59.9
≥60
Comorbidities
Hypertension
Diabetes mellitus
Chronic obstructive pulmonary disease
Renal disease
Atrial fibrillation
Mean Charlson Comorbidity Index
(mean ± SE)
Hospital characteristics
Bed size
Small
Medium
Large
Teaching status (urban)
Nonteaching
Teaching

Non-HF

Systolic HF

Diastolic HF

Total

788,195 (99.3%)

1915 (0.2%)

3301 (0.4%)

793,411

46.5%
46.7%
7.4%
87.3%

50.1%
46.8%
3.9%
60.0%

55.4%
41.7%
4.8%
66.6%

45.61 ± 0.03

59.9 ± 0.77

22.5%
77.5%

55.0%
45.0%

67.3%
15.8%
12.1%
4.8%

62.3%
24.4%
7.7%
5.7%

3.1%
19.7%
31.8%
20.6%
19.1%
5.7%

7.1%
12.4%
23.5%
19.9%
26.1%
11.1%

55.4%
30.4%
18.9%
2.2%
1.9%
0.8 ± 0.003

76.23%
46.3%
39.0%
21.9%
28.7%
3.24 ± 0.088

18.9%
29.3%
51.8%

11.9%
24.0%
64.1%

35.0%
65.0%

29.0%
71.0%

P⁎
<.001
<.001

61.37 ± 0.51

P†
<.001
<.001

39.8%
60.2%
<.001

<.001
71.1%
20.0%
3.4%
5.5%

<.001

<.001
4.4%
11.6%
20.3%
22.6%
27.9%
13.2%

<.001
<.001
<.001
<.001
<.001
<.001

80.3%
54.9%
43.5%
23.6%
24.3%
2.56 ± 0.07

<.001

<.001
<.001
<.001
<.001
<.001
<.001

<.001
11.8%
27.7%
60.5%

.01

<.001
28.1%
71.9%

⁎ P values reflect comparison between systolic HF and individuals with non-HF.
† P values reflect comparison between diastolic HF and individuals with non-HF.

(99.3%) patients had non-HF, 1,915 (0.2%) had preexisting systolic HF, and 3,301 (0.4%) had diastolic HF. Gastric
bypass and sleeve gastrectomy were the most common
bariatric procedures, accounting for >90% of the surgical
procedures in each group. Laparoscopic surgery was the
most common approach across all cohorts (non-HF:
87.3%, systolic HF: 60.0%, diastolic HF: 66.6%); HF
patients were more likely to undergo conventional
open surgery when compared to non-HF. Baseline
characteristics are described in Table I.
In-hospital mortality among non-HF patients undergoing bariatric surgery was 0.4%. Compared to non-HF
patients, systolic HF was independently associated with
higher in-hospital mortality (10.3%, adjusted odds ratio
[aOR] 3.14; 95% CI 2.02-4.9; P < .001). Diastolic HF
patients demonstrated a nonsignificant trend toward

higher in-hospital mortality when compared with nonHF (5.7%, aOR 1.55; 95% CI 0.99-2.43; P = .056). Among
the subgroup of patients undergoing laparoscopic
surgery, in-hospital mortality in the non-HF cohort was
lower at 0.04%. Patients with systolic HF undergoing
laparoscopic surgery had a signal toward higher inhospital mortality (1.4%, aOR 4.84; 95% CI 0.99-23.8; P =
.05), and those with diastolic HF had significantly
increased in-hospital mortality compared to non-HF
patients (1.8%; aOR 8.98; 95% CI 3.3-24.4; P < .001).
Patients with baseline systolic HF and diastolic HF had a
higher incidence of in-hospital complications than nonHF patients. Excess risk for systolic HF and diastolic HF
patients was particularly noted for myocardial infarction
(9.0% for systolic HF and 3.0% for diastolic HF vs 0.1%
non-HF, P < .001), atrial fibrillation (28.7% and 24.3% vs
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Figure 1

Adjusted outcomes of HF patients undergoing bariatric surgery (reference = non-HF).**Adjusted for age, sex, race, hospital bed size, hospital
teaching status, and Charlson Comorbidity Index. ±Statistical model for systolic HF failed due to small sample size.

1.9%, P < .001), hospital-acquired pneumonia (12.7%
and 10.4% vs 0.82%, P < .001), respiratory failure
(16.8% and 16.9% vs 1.0%, P < .001), sepsis (16.5% and
12.7% vs 1.04%, P < .001), and acute kidney injury
(27.9% and 25.9% vs 1.9%, P < .001) (Figure 1). Some
complications were noted to be higher in a specific HF
subgroup; when compared to patients without HF,
patients with systolic HF were more likely to have acute
kidney injury requiring dialysis (3.6% vs 0.1%, P < .001)
and bleeding requiring transfusion (9.6% vs 1.4%, P =
.002), whereas patients with diastolic HF were more
likely to have pulmonary edema (0.6% vs 0.04%,
P < .001) and cardiac arrest (1.4% vs 0.1%, P = .038).
Patients with HF had a longer length of hospital stay
(systolic HF mean 13.2 days [P < .001] and diastolic HF
mean 10.3 days [P < .001] vs non-HF mean 2.8 days).
Bariatric surgery is the most effective strategy for
achieving significant and sustained weight loss for patients
with severe obesity and is associated with reduction in
longer-term risk of cardiovascular disease and mortality.
The benefit of surgical weight loss strategies in patients
with established HF is less clear. According to our analysis,
despite a high prevalence of comorbid obesity, only a small
proportion of bariatric surgeries in the US are performed in
patients with HF. Furthermore, systolic HF or diastolic HF is
independently associated with higher risk of in-hospital
complications and significantly higher in-hospital mortality.
Contemporary studies describe 30-day postoperative
mortality rates in the range of 0.04%-0.3% for bariatric
procedures. 5 , 8 The presently reported 0.4% in-hospital
mortality among patients without HF in our overall cohort
and 0.04% in the laparoscopic cohort is consistent with
these prior observations.
Since the 1991 National Institutes of Health consensus
statement on eligibility for bariatric surgery, 9 more

information has become available on the safety and
efficacy of bariatric surgery in higher-risk populations
such as patients with poorly controlled type 2 diabetes, 10
yet the literature for bariatric surgery in patients with HF
has remained sparse and without prospective data. Based
on limited data, a Consensus Statement from the Heart
Failure Society of America recommended consideration
of bariatric surgery for selected patients with a BMI ≥
35 kg/m 2 and NYHA functional class II-III HF with or
without a left ventricular assist device, within an
experienced multidisciplinary team. 11
Notable in the current study is the dramatic excess inhospital mortality for patients with baseline HF, particularly for those with systolic HF. The 10.1% postoperative
mortality for patients with systolic HF is much higher
than anticipated for bariatric surgery candidates in
general and is an important finding for cardiologists,
bariatric surgeons, and patients to be aware of during
shared decision making regarding obesity management
options. As anticipated, the risk in laparoscopic surgery is
overall lower, but HF patients undergoing laparoscopic
surgery still carry excess of mortality when compared to
non-HF patients. Careful candidate selection, meticulous
presurgical optimization of cardiovascular status, and an
experienced multispecialty surgical and cardiology team
are likely to be essential features for successful outcomes
for patients with HF considering bariatric surgery.
To our knowledge, this is the largest real-world analysis
of bariatric surgery in patients with HF, yet limitations of
this analysis should be acknowledged. First, observational
data cannot prove cause-effect relationships and may be
subject to residual or unmeasured confounding. Second,
the diagnoses of HF and other comorbidities are
dependent upon ICD-9 coding availability and accuracy.
It is possible that the non-HF group may have included
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some patients with HF; however, patients with significant
HF were likely to be appropriately coded. Furthermore,
ejection fraction parameters are not reported in this
database. To avoid misinterpretation of the data, we
maintained the diagnosis of systolic and diastolic as they
were originally reported in the database. Third, outcome
measures from the NIS relate only to in-hospital outcomes
and do not capture longer-term follow-up. Lastly, details
related to hospital expertise or case volume were not
available for either bariatric surgery or HF cardiology
care, and it is possible that in-hospital risk was
successfully mitigated at select centers.
As compared with the general population of patients
receiving bariatric surgery, HF can be associated with an
excess risk of early postoperative complications and inhospital mortality. These potential risks should prompt
shared decision-making between patients and clinicians
when considering bariatric surgery in the setting of
concurrent HF. Prospective randomized trials are urgently needed to define appropriate candidate selection and
enable stakeholders to balance potential long-term health
benefits against early procedural risks in HF patients.
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